NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

I will take a look, HFTF, but I don't really know how much more additional information they can give us about the P1. I thought the report we have both got was pretty comprehensive, including measures of PD-L1 upregulation, T-cell infiltration and cytokine levels.

Would be nice to know about any survivees, of course. But as a P1, long term follow-up was not an official endpoint.
It demonstrated all-important safety and that there were no dose-limiting toxicities.
And it established that Method B was better.